Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-030049
Filing Date
2020-10-30
Accepted
2020-10-30 21:28:29
Documents
1
Period of Report
2020-10-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3054
  Complete submission text file 0000899243-20-030049.txt   4553
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12 EAGLE KNOLL COURT LAS VEGAS NV 89141
Business Address 12 EAGLE KNOLL COURT LAS VEGAS NV 89141 619-518-4637
Lockend Five, LLC (Reporting) CIK: 0001830602 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35921 | Film No.: 201278784